Logo
Apparel & Fashion

Description

Lacosamide API represents a high-purity active pharmaceutical ingredient manufactured under strict regulatory compliance and quality control standards. Available in IP, BP, EP, and USP grades, this antiepileptic compound meets global pharmacopeia requirements for pharmaceutical applications. Our manufacturing facilities maintain FDA approval and state certifications, ensuring consistent quality and regulatory adherence. The ready stock availability guarantees immediate supply for manufacturers requiring reliable bulk drug ingredients without production delays. Each batch comes with comprehensive documentation including certificates of analysis and stability data to support regulatory submissions and manufacturing processes.

This pharmaceutical ingredient serves manufacturers specializing in neurology and central nervous system medications, including generic drug producers, hospital pharmacies, and compounding facilities. The API is essential for developing anticonvulsant therapies tha...
Lacosamide API represents a high-purity active pharmaceutical ingredient manufactured under strict regulatory compliance and quality control standards. Available in IP, BP, EP, and USP grades, this antiepileptic compound meets global pharmacopeia requirements for pharmaceutical applications. Our manufacturing facilities maintain FDA approval and state certifications, ensuring consistent quality and regulatory adherence. The ready stock availability guarantees immediate supply for manufacturers requiring reliable bulk drug ingredients without production delays. Each batch comes with comprehensive documentation including certificates of analysis and stability data to support regulatory submissions and manufacturing processes.

This pharmaceutical ingredient serves manufacturers specializing in neurology and central nervous system medications, including generic drug producers, hospital pharmacies, and compounding facilities. The API is essential for developing anticonvulsant therapies that address partial-onset seizures and neuropathic pain conditions. Industries value the multiple pharmacopeia compliance that supports market approvals across different regions, including requirements from USFDA, EMA, and other global health authorities. The injectable grade specifically supports parenteral formulation developers who require sterile API for critical care medications and hospital applications.

Businesses select our Lacosamide API for its proven reliability in manufacturing consistency and comprehensive regulatory support. We provide complete documentation packages that reduce validation efforts and accelerate time-to-market for new formulations. The consistent batch-to-batch quality ensures therapeutic efficacy and manufacturing process stability. Our supply chain management guarantees uninterrupted availability, minimizing production disruptions while maintaining the highest quality standards. The product's compliance with multiple pharmacopeia standards makes it suitable for global market applications and regulatory requirements.

Key Features:
- Available in IP, BP, EP, USP, and injectable pharmacopeia grades
- Manufactured in FDA-approved facilities with state certifications
- Ready stock availability for immediate global shipment
- Comprehensive documentation including COA and stability data
- Multiple pharmacopeia compliance for global market access

Benefits:
- Accelerated regulatory approvals with complete documentation support
- Consistent batch-to-batch quality for manufacturing reliability
- Immediate availability reduces production timeline delays
- Global pharmacopeia compliance enables international market access
- Proven therapeutic efficacy in seizure control medications

Specifications

Additional Information
Country of OriginIndia

Application

Lacosamide API serves as a critical antiepileptic active pharmaceutical ingredient for manufacturing seizure control medications. This high-purity compound is formulated into tablets, injectables, and oral solutions for treating partial-onset seizures and neuropathic pain conditions. The multiple pharmacopeia compliance ensures adherence to global quality standards for safe pharmaceutical manufacturing and patient use. Pharmaceutical manufacturers and compounding facilities rely on this API for producing both branded and generic anticonvulsant therapies. The consistent quality and regulatory compliance make it essential for neurology and pain management treatment formulations. Industries value the batch-to-batch consistency for maintaining therapeutic efficacy and meeting strict pharmaceutical manufacturing requirements across different dosage forms and markets. - Manufacturing oral tablets for partial-onset epilepsy treatment - Producing injectable solutions for hospital and clinical settings - Formulating syrups for pediatric and geriatric patient populations - Compounding customized dosage forms in pharmacy environments - Developing generic anticonvulsant therapies for affordable treatment options

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

A. S. Joshi & Company, Maharashtra
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Lacosamide API IP BP EP USP Injectable FDA Approved

Lacosamide API IP BP EP USP injectable FDA approved bulk pharmaceutical ingredient for seizure control medications. High-purity antiepileptic active pharmaceutical ingredient manufactured in certified facilities with ready stock availability for immediate global supply.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

A. S. Joshi & Company
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler

More Products From Supplier